Per oral substitution with 300000 IU vitamin D (Cholecalciferol) reduces bone turnover markers in HIV-infected patients

Table 3 Univariate analysis for response to vitamin D

	Responder	Non responder	OR	CI	p-value
HCV	25	8	1.59	0.78-3.23	0.18
No HCV	27	17
IVDU	23	6	1.91	0.86-4.23	0.08
No IVDU	29	19
Treatment	48	16	2.76	1.58-4.03	0.002
No Treatment	4	9
TDF	36	13	1.61	0.85-3.04	3.04
No TDF	16	12
NNRTI*	27	6	1.9	0.78-4.57	0.14
PI	19	10
Male	28	14	0.76	0.4-1.46	0.65
Female	24	11
African descent	12	8	1.34	0.68-2.61	0.4
No african descent	40	17
Age < 40	18	10	0.85	0.44-1.64	0.21
Age > 40	34	15
BMI < 21	7	2	1.52	0.43-5.4	0.48
BMI > 21	45	23
Smoker	32	13	1.29	0.68-2.49	0.42
Non smoker	20	12
Vit D 30-75 nmol/L	38	17	0.97	0.47-2.01	0.92
Vit D < 30 nmol/L	15	7
Total	52	25

ISSN: 1471-2334